Unanswered questions regarding the management of sunitinib-induced hypothyroidism

Nat Clin Pract Oncol. 2007 Dec;4(12):674. doi: 10.1038/ncponc0998. Epub 2007 Oct 23.

Authors

David Garfield¹, Aleck Hercbergs, Paul Davis

Affiliation

¹ Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80209, USA. [email protected]

PMID: 17955044
DOI: 10.1038/ncponc0998

No abstract available

MeSH terms

Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects*
Drug Therapy, Combination
Humans
Hypothyroidism / chemically induced*
Hypothyroidism / drug therapy*
Indoles / administration & dosage
Indoles / adverse effects*
Neoplasms / drug therapy*
Neoplasms / physiopathology
Pyrroles / administration & dosage
Pyrroles / adverse effects*
Sunitinib
Thyroid Hormones / administration & dosage
Thyroid Hormones / adverse effects*

Substances

Antineoplastic Agents
Indoles
Pyrroles
Thyroid Hormones
Sunitinib